Wendy Chung

Insider Reports History

Location
Prime Medicine, Inc., 21 Erie St., Cambridge, MA
Signature
/s/ Ryan Brown, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Wendy Chung:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rallybio Corp Director Option (Right to Buy) 16.5K $29.2K $1.77 May 15, 2024 Direct
Prime Medicine, Inc. Director Stock Option (right to buy) 45K Aug 1, 2025 Direct
Rallybio Corp Director Option (Right to Buy) 28.5K May 13, 2025 Direct

Insider Reports Filed by Wendy Chung

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRME Prime Medicine, Inc. Aug 1, 2025 8 $0 4 Aug 5, 2025 Director
PRME Prime Medicine, Inc. Jun 4, 2025 1 $0 4 Jun 5, 2025 Director
RLYB Rallybio Corp May 13, 2025 1 $0 4 May 15, 2025 Director
PRME Prime Medicine, Inc. Jun 12, 2024 1 $0 4 Jun 14, 2024 Director
RLYB Rallybio Corp May 15, 2024 1 $0 4 May 17, 2024 Director
PRME Prime Medicine, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
RLYB Rallybio Corp May 17, 2023 1 $0 4 May 19, 2023 Director
RLYB Rallybio Corp Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
PRME Prime Medicine, Inc. Oct 19, 2022 1 $0 4 Oct 21, 2022 Director
PRME Prime Medicine, Inc. Oct 19, 2022 0 $0 3 Oct 19, 2022 Director
RLYB Rallybio Corp Aug 1, 2022 1 $0 4 Aug 3, 2022 Director
RLYB Rallybio Corp Aug 1, 2022 0 $0 3 Aug 3, 2022 Director